1592U89 nucleoside reverse transcriptase inhibitor: Glaxo began an open-label compassionate use program in pediatric AIDS patients at risk for disease progressi

Glaxo Wellcome Inc., Research Triangle

Read the full 57 word article

How to gain access

Continue reading with a
two-week free trial.